Patients with Social and Financial Challenges Less Likely to Receive Certain Anticoagulants

Physicians who participated in a survey said that these drugs were less likely to be prescribed if the patient could not afford the drug or lacked health insurance.

Key Highlights

  • - Patients with financial difficulties or no insurance are less likely to receive prescribed anticoagulants for blood clots.
  • - Housing insecurity and language barriers influence physicians' decisions on prescribing DOACs for VTE treatment.
  • - The study emphasizes the need to address social determinants to ensure equitable healthcare access.
  • - Clinical guidelines recommend DOACs for most VTE patients, but socioeconomic factors hinder their implementation.
  • - Findings suggest healthcare disparities that could lead to worse outcomes for vulnerable populations.

A Michigan Medicine-led study found that people who experience social and financial challenges are less likely to receive certain anticoagulant prescriptions.

These medications, called DOACs, or direct oral anticoagulants, treat potentially deadly blood clots. Physicians were less likely to prescribe them if the patient had issues affording the drug or had no health insurance.

Clinical guidelines recommend that most patients with venous thromboembolism, or VTE, be prescribed DOACs. VTE causes clots to form in the veins and block blood flow. It includes deep vein thrombosis, which involves clots in the legs, and pulmonary embolism, the result of a clot blocking the artery in the lungs.

Physicians who participated in the survey noted that patients with housing insecurity were less likely to receive a DOAC, and a patient’s ability to natively speak English also affected medical management.

About the Author

Matt MacKenzie

Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

Sign up for our eNewsletters
Get the latest news and updates